311 results on '"Spring, David R."'
Search Results
2. CK2 Inhibitors Targeting Inside and Outside the Catalytic Box
3. Unlocking Amides: A General Method for the Self‐Immolative Release of Amide‐Containing Molecules
4. Unlocking Amides: A General Method for the Self‐Immolative Release of Amide‐Containing Molecules
5. Site-selective peptide functionalisation mediated via vinyl-triazine linchpins
6. Red-light modulated ortho-chloro azobenzene photoswitch for peptide stapling via aromatic substitution
7. Tryptophan in Multicomponent Petasis Reactions for Peptide Stapling and Late‐Stage Functionalisation
8. Tryptophan in Multicomponent Petasis Reactions for Peptide Stapling and Late‐Stage Functionalisation
9. Selective inhibitors of the Aurora A-TPX2 protein-protein interaction exhibit in vivo efficacy as targeted anti-mitotic agents
10. A Recombinant Approach For Stapled Peptide Discovery Yields Inhibitors of the RAD51 Recombinase
11. The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance
12. Front Cover: Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance (ChemMedChem 2/2023)
13. A Recombinant Approach For Stapled Peptide Discovery Yields Inhibitors of the RAD51 Recombinase
14. Identification of macrocyclic peptides which activate bacterial cylindrical proteases
15. Synthesis of sp3-rich heterocyclic frameworks by a divergent synthesis strategy
16. Peroxide-cleavable linkers for antibody–drug conjugates
17. Disulfide re-bridging reagents for single-payload antibody-drug conjugates
18. A cell-active peptide targeting the Nrf2/Keap1 protein-protein interaction
19. Chapter 2. The Application of Diversity-oriented Synthesis in Chemical Biology
20. Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance
21. LGR5 targeting molecules as therapeutic agents for multiple cancer types
22. A unified in vitro to in vivo fluorescence lifetime screening platform yields amyloid β aggregation inhibitors
23. Antibody dual-functionalisation enabled through a modular divinylpyrimidine disulfide rebridging strategy
24. Non-internalising antibody–drug conjugates
25. Divinylpyrimidine reagents generate antibody–drug conjugates with excellent in vivo efficacy and tolerability
26. All-in-one disulfide bridging enables the generation of antibody conjugates with modular cargo loading
27. Development of small cyclic peptides targeting the CK2α/β interface
28. Correction: The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions
29. A fragment-based approach leading to the discovery of inhibitors of CK2α with a novel mechanism of action
30. Energetics of lipid transport by the ABC transporter MsbA is lipid dependent
31. Targeting a Novel KRAS Binding Site: Application of One-Component Stapling of Small (5–6-mer) Peptides
32. New Advances in Diversity-Oriented Synthesis
33. Diversity-Oriented Synthesis: Developing New Chemical Tools to Probe and Modulate Biological Systems
34. Microscopy and chemical analyses reveal flavone-based woolly fibres extrude from micron-sized holes in glandular trichomes of Dionysia tapetodes
35. Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study
36. Peptides as a platform for targeted therapeutics for cancer: peptide–drug conjugates (PDCs)
37. Site-selective modification strategies in antibody–drug conjugates
38. Chemical probes targeting the kinase CK2: a journey outside the catalytic box
39. The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions
40. The role of chemical synthesis in developing RiPP antibiotics
41. Rapid and robust cysteine bioconjugation with vinylheteroarenes
42. A dual-enzyme cleavable linker for antibody–drug conjugates
43. Photocatalytic methods for amino acid modification
44. The Basics of Diversity-Oriented Synthesis
45. Expeditious Total Synthesis of Hemiasterlin through a Convergent Multicomponent Strategy and Its Use in Targeted Cancer Therapeutics
46. Expeditious Total Synthesis of Hemiasterlin through a Convergent Multicomponent Strategy and Its Use in Targeted Cancer Therapeutics
47. Formation of flavone-based wooly fibres by glandular trichomes of Dionysia tapetodes
48. Diversity-Oriented Synthesis
49. Diversity-Oriented Synthesis
50. An Introduction to Diversity-Oriented Synthesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.